THERMO FISHER SCIENTIFIC INC. (NYSE:TMO) Files An 8-K Other Events

ME Staff 8-k
-
0

THERMO FISHER SCIENTIFIC INC. (NYSE:TMO) Files An 8-K Other Events
Item 8.01. Other Events.

On August29, 2017, Thermo Fisher Scientific Inc. (the “Company”) issued a press release announcing the expiration and results of the previously announced tender offer by Thermo Fisher (CN) Luxembourg S.à r.l., a wholly owned subsidiary of the Company, to purchase all of the outstanding ordinary shares of Patheon N.V.

A copy of the press release is attached hereto as Exhibit99.1 and is incorporated herein by reference.

Item 9.01. Financial Statements and Exhibits.

(d)Exhibits

Exhibit

No.

Description

99.1

Press Release, dated August29, 2017.


THERMO FISHER SCIENTIFIC INC. Exhibit
EX-99.1 2 a17-21063_1ex99d1.htm EX-99.1 Exhibit 99.1     Thermo Fisher Scientific Completes Acquisition of Patheon   WALTHAM,…
To view the full exhibit click here

About THERMO FISHER SCIENTIFIC INC. (NYSE:TMO)

Thermo Fisher Scientific Inc. develops, manufactures and sells a range of products. The Company is a provider of analytical instruments, equipment, reagents and consumables, software and services for research, manufacturing, analysis, discovery and diagnostics. The company operates through four segments: Life Sciences Solutions, Analytical Instruments, Specialty Diagnostics, and Laboratory Products and Services. Through the Life Sciences Solutions segment, it provides reagents, instruments and consumables used in biological and medical research, discovery and production of new drugs and vaccines, as well as diagnosis of disease. Through the Analytical Instruments segment, it provides instruments, consumables, software and services. The Specialty Diagnostics segment offers diagnostic test kits, reagents, culture media, instruments and associated products. The Laboratory Products and Services segment offers self-manufactured and sourced products for the laboratory.